A 44-year-old female, a non-smoker and with no comorbidities, was diagnosed with stage IIIB poorly differentiated lung adenocarcinoma in the left lower lobe (Fig. 1a), harbouring an activating EGFR ex19del mutation. This evidence concerns the gene EGFR and lung adenocarcinoma.